Skip to content

SILVERARC CAPITAL MANAGEMENT, LLC

Follow

13F filer, CIK 1816307, BOSTON, MA

SILVERARC CAPITAL MANAGEMENT, LLC reported $854,443,588 across 70 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-12. Its ten largest share positions make up 54.15% of the portfolio.

Accepted , ingested 13F-HR 0001420506-26-002577

Period
2026-09-30
Reported value
$854M
Holdings
70
Top 10 weight
54.15%
New
18
Sold out
21

Stakes and trades reported after 2026-09-30

13D, 13G and Form 4 filings by this filer's group, dated after the 13F period, on securities the quarter does not hold as shares.

  • IRLA QUINCE THERAPEUTICS INC: 13G/A 880,255 shares, 7.9% of the class, 13G/A filed 2026-11-16, 0001104659-26-128354Timeline
    Accepted , ingested

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CELCadded+302,197$24M
GLUEadded+2,004,478$23.9M
KODadded+203,914$19.3M
CLDXnew+487,589$15.8M
BIIBadded+64,689$14.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VCYTexited-318,001-$18.7M
SNDXreduced-966,972-$18.2M
ELVNreduced-367,930-$16.9M
GHexited-99,826-$15M
DNTHreduced-153,418-$13.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001420506-26-002577, largest first. % of portfolio is the value over $820,947,677, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,000,000 shares; 2025Q1: 441,807 shares; 2025Q2: 401,540 shares; 2025Q3: 1,000,000 shares; 2025Q4: 1,023,122 shares; 2026Q1: 991,930 shares; 2026Q2: 546,256 shares; 2026Q3: 750,170 shares 750,170$71.1M8.66%+203,914Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 88,686 shares; 2025Q4: 375,132 shares; 2026Q1: 357,903 shares; 2026Q2: 500,996 shares; 2026Q3: 803,193 shares 803,193$63.9M7.78%+302,197Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 921,137 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 815,075 shares; 2025Q4: 1,245,254 shares; 2026Q1: 1,314,189 shares; 2026Q2: 1,280,707 shares; 2026Q3: 1,574,698 shares 1,574,698$50.4M6.14%+293,991Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,120,473 shares; 2025Q1: 1,381,158 shares; 2025Q2: 2,022,482 shares; 2025Q3: 1,577,283 shares; 2025Q4: 1,738,821 shares; 2026Q1: 1,503,045 shares; 2026Q2: 1,301,979 shares; 2026Q3: 1,148,689 shares 1,148,689$46.7M5.69%-153,290Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,126,210 shares; 2026Q1: 1,850,278 shares; 2026Q2: 2,017,009 shares; 2026Q3: 2,092,715 shares 2,092,715$45M5.48%+75,706Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 694,942 shares; 2025Q4: 1,029,066 shares; 2026Q1: 2,002,040 shares; 2026Q2: 1,108,295 shares; 2026Q3: 3,112,773 shares 3,112,773$37.1M4.52%+2,004,478Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,539 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,927,698 shares; 2026Q3: 3,745,990 shares 3,745,990$37M4.51%+818,292Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 206,234 shares; 2026Q3: 152,175 shares 152,175$34.7M4.22%-54,059Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 273,896 shares; 2025Q1: 337,605 shares; 2025Q2: 400,772 shares; 2025Q3: 369,996 shares; 2025Q4: 135,950 shares; 2026Q1: 306,000 shares; 2026Q2: 311,461 shares; 2026Q3: 348,317 shares 348,317$33.2M4.04%+36,856Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 80,419 shares; 2025Q4: 75,412 shares; 2026Q1: 50,967 shares; 2026Q2: 48,101 shares; 2026Q3: 112,790 shares 112,790$25.5M3.1%+64,689Timeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: not reported; 2026Q1: 414,236 shares; 2026Q2: 619,096 shares; 2026Q3: 624,055 shares 624,055$21.1M2.57%+4,959Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 190,334 shares; 2025Q2: 95,806 shares; 2025Q3: 674,966 shares; 2025Q4: 750,136 shares; 2026Q1: 654,746 shares; 2026Q2: 390,000 shares; 2026Q3: 236,582 shares 236,582$20.8M2.54%-153,418Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 165,389 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 150,908 shares; 2026Q2: 352,802 shares; 2026Q3: 247,918 shares 247,918$20.6M2.52%-104,884Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,543,901 shares; 2025Q1: 7,367,996 shares; 2025Q2: 2,569,591 shares; 2025Q3: 1,368,075 shares; 2025Q4: 1,317,584 shares; 2026Q1: 1,851,812 shares; 2026Q2: 1,263,026 shares; 2026Q3: 1,330,455 shares 1,330,455$19.5M2.38%+67,429Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 285,120 shares; 2025Q1: 210,901 shares; 2025Q2: not reported; 2025Q3: 539,704 shares; 2025Q4: 422,193 shares; 2026Q1: 302,530 shares; 2026Q2: 169,593 shares; 2026Q3: 175,699 shares 175,699$17.4M2.12%+6,106Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 264,560 shares; 2025Q1: 205,962 shares; 2025Q2: 198,441 shares; 2025Q3: 348,922 shares; 2025Q4: 191,074 shares; 2026Q1: 178,378 shares; 2026Q2: not reported; 2026Q3: 487,589 shares 487,589$15.8M1.92%newTimeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 3,101,129 shares; 2026Q3: 5,950,000 shares 5,950,000$14.8M1.8%+2,848,871Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 187,737 shares; 2026Q1: 186,618 shares; 2026Q2: 59,959 shares; 2026Q3: 151,151 shares 151,151$13.5M1.64%+91,192Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares; 2026Q3: 345,946 shares 345,946$13.2M1.6%-54,054Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,208,986 shares; 2026Q2: 1,177,821 shares; 2026Q3: 1,208,030 shares 1,208,030$12.8M1.56%+30,209Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 124,871 shares; 2025Q2: not reported; 2025Q3: 180,513 shares; 2025Q4: not reported; 2026Q1: 460,314 shares; 2026Q2: 113,494 shares; 2026Q3: 300,427 shares 300,427$12.2M1.48%+186,933Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,221,131 shares; 2025Q1: 882,300 shares; 2025Q2: not reported; 2025Q3: 1,897,383 shares; 2025Q4: 1,994,224 shares; 2026Q1: 1,911,785 shares; 2026Q2: 3,032,060 shares; 2026Q3: 3,454,647 shares 3,454,647$11.5M1.4%+422,587Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 330,487 shares; 2026Q3: 378,352 shares 378,352$10.8M1.31%+47,865Timeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,587,228 shares; 2025Q1: 2,456,537 shares; 2025Q2: 2,488,291 shares; 2025Q3: 2,715,786 shares; 2025Q4: 2,814,383 shares; 2026Q1: 3,176,547 shares; 2026Q2: 3,472,737 shares; 2026Q3: 3,950,595 shares 3,950,595$9.4M1.15%+477,858Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,744,757 shares; 2026Q3: 6,565,960 shares 6,565,960$9.13M1.11%+821,203Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,135,935 shares; 2026Q2: 509,789 shares; 2026Q3: 334,057 shares 334,057$9.01M1.1%-175,732Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,000 shares; 2026Q2: 503,382 shares; 2026Q3: 717,356 shares 717,356$8.92M1.09%+213,974Timeline
RNAQURAINIER ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 853,875 shares 853,875$8.71M1.06%newTimeline
CGENCOMPUGEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,624,377 shares; 2025Q1: 2,895,430 shares; 2025Q2: 3,033,879 shares; 2025Q3: 3,311,165 shares; 2025Q4: 3,479,805 shares; 2026Q1: 3,315,845 shares; 2026Q2: 3,184,257 shares; 2026Q3: 3,586,785 shares 3,586,785$8.54M1.04%+402,528Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,430,982 shares; 2026Q2: 1,355,459 shares; 2026Q3: 1,518,833 shares 1,518,833$7.84M0.95%+163,374Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 40,788 shares; 2025Q1: not reported; 2025Q2: 287,796 shares; 2025Q3: 314,339 shares; 2025Q4: 148,787 shares; 2026Q1: 144,981 shares; 2026Q2: 145,000 shares; 2026Q3: 125,080 shares 125,080$7.12M0.87%-19,920Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 301,919 shares 301,919$6.8M0.83%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,000 shares; 2026Q1: 226,000 shares; 2026Q2: 3,520,490 shares; 2026Q3: 5,357,088 shares 5,357,088$6.32M0.77%+1,836,598Timeline
ARCTARCTURUS THERAPEUTICS HLDGSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,445 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 459,899 shares 459,899$6.3M0.77%newTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 72,516 shares; 2025Q1: 166,074 shares; 2025Q2: 10,000 shares; 2025Q3: 51,210 shares; 2025Q4: 82,465 shares; 2026Q1: 71,552 shares; 2026Q2: 65,679 shares; 2026Q3: 19,753 shares 19,753$5.75M0.7%-45,926Timeline
KNSAKINIKSA PHARMACEUTICALS INTLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 88,215 shares; 2025Q2: 75,959 shares; 2025Q3: 88,910 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 75,697 shares 75,697$5.65M0.69%newTimeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 10,675 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 489,382 shares; 2026Q3: 121,452 shares 121,452$5.57M0.68%-367,930Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 452,239 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 668,450 shares; 2026Q3: 760,337 shares 760,337$5.5M0.67%+91,887Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 594,027 shares 594,027$4.91M0.6%newTimeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,230,400 shares; 2025Q1: 1,309,224 shares; 2025Q2: 402,964 shares; 2025Q3: 463,708 shares; 2025Q4: 642,899 shares; 2026Q1: 888,987 shares; 2026Q2: 1,214,390 shares; 2026Q3: 247,418 shares 247,418$4.65M0.57%-966,972Timeline
BNTCBENITEC BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 250,000 shares; 2025Q2: 253,234 shares; 2025Q3: 276,267 shares; 2025Q4: 731,717 shares; 2026Q1: 717,725 shares; 2026Q2: 679,826 shares; 2026Q3: 443,109 shares 443,109$4.43M0.54%-236,717Timeline
RACCRESEARCH ALLIANCE CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 360,000 shares; 2026Q3: 404,728 shares 404,728$4.38M0.53%+44,728Timeline
BLSMBLOSSOMHILL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 202,104 shares 202,104$3.77M0.46%newTimeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 124,098 shares 124,098$3.69M0.45%newTimeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 917,898 shares; 2025Q3: 994,754 shares; 2025Q4: 627,738 shares; 2026Q1: 648,942 shares; 2026Q2: 610,407 shares; 2026Q3: 693,441 shares 693,441$3.64M0.44%+83,034Timeline
RACDRESEARCH ALLIANCE CORP IVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 301,962 shares 301,962$3.5M0.43%newTimeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 216,617 shares 216,617$3.47M0.42%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 102,108 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,335,602 shares 2,335,602$3.15M0.38%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 110,381 shares; 2025Q1: 236,471 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 196,028 shares; 2026Q2: 82,800 shares; 2026Q3: 47,312 shares 47,312$3.1M0.38%-35,488Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,065,649 shares; 2025Q1: 2,771,288 shares; 2025Q2: 2,779,795 shares; 2025Q3: 2,782,923 shares; 2025Q4: 2,647,512 shares; 2026Q1: 2,259,312 shares; 2026Q2: 2,137,201 shares; 2026Q3: 2,137,201 shares 2,137,201$2.46M0.3%0Timeline
ZVRAZEVRA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,260 shares 200,260$2.2M0.27%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,178,300 shares; 2025Q1: 2,060,240 shares; 2025Q2: 1,800,829 shares; 2025Q3: 1,948,808 shares; 2025Q4: 1,116,604 shares; 2026Q1: 1,100,010 shares; 2026Q2: 738,873 shares; 2026Q3: 160,552 shares 160,552$2.16M0.26%-578,321Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 166,161 shares; 2025Q4: 307,540 shares; 2026Q1: 301,729 shares; 2026Q2: 296,135 shares; 2026Q3: 158,964 shares 158,964$2.13M0.26%-137,171Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,000 shares 10,000$1.93M0.23%newTimeline
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,782,271 shares; 2025Q1: 2,670,056 shares; 2025Q2: 2,761,684 shares; 2025Q3: 2,850,987 shares; 2025Q4: 2,751,314 shares; 2026Q1: 2,498,020 shares; 2026Q2: 2,192,980 shares; 2026Q3: 2,192,980 shares 2,192,980$1.73M0.21%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 100,000 shares; 2025Q1: 203,400 shares; 2025Q2: 202,565 shares; 2025Q3: 455,000 shares; 2025Q4: 126,047 shares; 2026Q1: not reported; 2026Q2: 105,000 shares; 2026Q3: 56,704 shares 56,704$1.37M0.17%-48,296Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 227,178 shares; 2026Q3: 158,950 shares 158,950$1.29M0.16%-68,228Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,946,482 shares; 2026Q3: 238,541 shares 238,541$1.25M0.15%-1,707,941Timeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 203,946 shares; 2025Q4: 9,659 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 35,524 shares 35,524$1.19M0.15%newTimeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 653,594 shares; 2025Q4: not reported; 2026Q1: 653,594 shares; 2026Q2: 653,594 shares; 2026Q3: 183,063 shares 183,063$740K0.09%-470,531Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 720,452 shares; 2025Q4: not reported; 2026Q1: 560,651 shares; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$416K0.05%newTimeline
CLRBCELLECTAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 321,728 shares; 2026Q3: 151,118 shares 151,118$278K0.03%-170,610Timeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 515,384 shares; 2026Q1: 251,972 shares; 2026Q2: 224,360 shares; 2026Q3: 170,460 shares 170,460$26.1K<0.01%-53,900Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
CELLDEX THERAPEUTICS INC NEWCELLDEX THERAPEUTICS INC NEW COM NEWcall370,700$12Mnew
ORIC PHARMACEUTICALS INCORIC PHARMACEUTICALS INC CALLcall702,400$9.46M+19,800
MONTE ROSA THERAPEUTICS INCMONTE ROSA THERAPEUTICS INC COMcall525,000$6.26M+225,000
ABSCI CORPORATIONABSCI CORPORATION COMput254,700$2.74M+97,100
FULCRUM THERAPEUTICS INCFULCRUM THERAPEUTICS INC COMcall391,900$1.45M0
ZURA BIO LTDZURA BIO LTD CALLcall242,200$1.01Mnew
ANNEXON INCANNEXON INC COMcall131,500$556Knew

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ARK ETF TRARK ETF TR500,000$21Mput
VCYTVERACYTE INC318,001$18.7Mshares
SYNDAX PHARMACEUTICALS INCSYNDAX PHARMACEUTICALS INC693,600$15.2Mcall
GHGUARDANT HEALTH INC99,826$15Mshares
TRVITREVI THERAPEUTICS INC678,095$12.6Mshares
MANEVERADERMICS INC95,000$11.7Mshares
XENEXENON PHARMACEUTICALS INC186,821$11.3Mshares
AVTXAVALO THERAPEUTICS INC500,402$9.25Mshares
WGSGENEDX HOLDINGS CORP122,269$8.39Mshares
ABIVAX SAABIVAX SA50,000$6.66Mcall
ARTVARTIVA BIOTHERAPEUTICS INC525,000$5.09Mshares
INSMINSMED INC34,438$3.67Mshares
KPTIKARYOPHARM THERAPEUTICS INC297,460$2.91Mshares
KYMERA THERAPEUTICS INCKYMERA THERAPEUTICS INC25,000$2.87Mput
RVMDREVOLUTION MEDICINES INC10,000$1.87Mshares
SIONSIONNA THERAPEUTICS INC42,478$1.87Mshares
GUTSFRACTYL HEALTH INC1,637,976$1.3Mshares
CNTBCONNECT BIOPHARMA HLDGS LTD545,000$1.3Mshares
CBIOCRESCENT BIOPHARMA INC.59,104$1.06Mshares
FHTXFOGHORN THERAPEUTICS INC45,975$224Kshares
RCKTWROCKET PHARMACEUTICALS INC104,828$356shares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-002577 base2026-11-12